The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 09, 2021
Filed:
Apr. 24, 2019
Applicant:
Tetraphase Pharmaceuticals, Inc., Watertown, MA (US);
Inventors:
Xiao-Yi Xiao, Lexington, MA (US);
Roger B. Clark, Lexington, MA (US);
Diana Katharine Hunt, Cambridge, MA (US);
Cuixiang Sun, Arlington, MA (US);
Magnus P. Ronn, Melrose, MA (US);
Wu-Yan Zhang, Lexington, MA (US);
Minsheng He, Andover, MA (US);
Assignee:
Tetraphase Pharmaceuticals, Inc., Watertown, MA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 207/09 (2006.01); C07D 207/08 (2006.01); C07D 221/18 (2006.01); C07D 471/04 (2006.01); C07C 237/26 (2006.01); C07D 295/155 (2006.01);
U.S. Cl.
CPC ...
C07D 207/09 (2013.01); C07C 237/26 (2013.01); C07D 207/08 (2013.01); C07D 221/18 (2013.01); C07D 295/155 (2013.01); C07D 471/04 (2013.01);
Abstract
The present invention is directed to a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof. The variables for Structural Formula (I) are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula (I), or a pharmaceutically acceptable salt thereof, and its therapeutic use.